Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Engelmann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Research|February 3, 2012
The dark side of E2F1: in transit beyond apoptosisDavid Engelmann, Brigitte M Pützer
Trends in Molecular Medicine|December 11, 2012
E2F1 apoptosis counterattacked: evil strikes backBrigitte M Pützer, David Engelmann
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 3, 2010
Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistanceDavid Engelmann, Brigitte M Pützer
Science Signaling|October 2, 2014
Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progressionDavid Engelmann, Brigitte M Pützer
Molecular Cancer|January 27, 2017
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuitAlf Spitschak, Claudia Meier, Bhavani Kowtharapu, et al.
Cellular and Molecular Life Sciences : CMLS|December 17, 2009
Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell deathDavid Engelmann, Susanne Knoll, Daniel Ewerth, et al.
Medical Microbiology and Immunology|September 29, 2006
Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytesInga Wilde, Sonja Lotz, David Engelmann, et al.
Biochimica Et Biophysica Acta|May 23, 2013
Hybrid modeling of the crosstalk between signaling and transcriptional networks using ordinary differential equations and multi-valued logicFaiz M Khan, Ulf Schmitz, Svetoslav Nikolov, et al.
Cancer Research|March 1, 2013
Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 networkJulio Vera, Ulf Schmitz, Xin Lai, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Research|February 3, 2012
The dark side of E2F1: in transit beyond apoptosisDavid Engelmann, Brigitte M Pützer
Trends in Molecular Medicine|December 11, 2012
E2F1 apoptosis counterattacked: evil strikes backBrigitte M Pützer, David Engelmann
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 3, 2010
Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistanceDavid Engelmann, Brigitte M Pützer
Science Signaling|October 2, 2014
Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progressionDavid Engelmann, Brigitte M Pützer
Molecular Cancer|January 27, 2017
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuitAlf Spitschak, Claudia Meier, Bhavani Kowtharapu, et al.
Cellular and Molecular Life Sciences : CMLS|December 17, 2009
Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell deathDavid Engelmann, Susanne Knoll, Daniel Ewerth, et al.
Medical Microbiology and Immunology|September 29, 2006
Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytesInga Wilde, Sonja Lotz, David Engelmann, et al.
Biochimica Et Biophysica Acta|May 23, 2013
Hybrid modeling of the crosstalk between signaling and transcriptional networks using ordinary differential equations and multi-valued logicFaiz M Khan, Ulf Schmitz, Svetoslav Nikolov, et al.
Cancer Research|March 1, 2013
Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 networkJulio Vera, Ulf Schmitz, Xin Lai, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Pageof 2